Volume 11, Issue 2 (6-2022)                   JCHR 2022, 11(2): 57-58 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Taheri Soodejani M, Mohammadi Abnavi M, Lotfi M H. How do Non-Communicable Diseases Increase COVID-19 Deaths?. JCHR 2022; 11 (2) :57-58
URL: http://jhr.ssu.ac.ir/article-1-775-en.html
1- Center for Healthcare Data Modeling, Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
2- Master student of Epidemiology, School of health, Shiraz University of Medical Sciences, Shiraz, Iran
3- Center for Healthcare Data Modeling, Departments of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran , mhlotfi56359@gmail.com
Abstract:   (1241 Views)
Coronavirus 2019 (COVID-19) is a novel respiratory viral disease which has caused a worldwide emergency due to its rapid spread and high mortality rate causing severe disorders (1). According to the latest reports by World Health Organization(WHO), as of May 2, 2021, 151.8 million people have been infected and 3.2 million deaths have been reported worldwide, most of which occurred in the United States, India, Brazil, France and Turkey respectively. In Iran, 2.5 million people have been infected and 72,000 deaths have been reported (2).
 
Full-Text [PDF 411 kb]   (537 Downloads) |   |   Full-Text (HTML)  (208 Views)  
Review: Letter to The Editor | Subject: Epidemiology
Received: 2021/06/9 | Accepted: 2022/06/20 | Published: 2022/07/5

References
1. Yang L, Liu S, Liu J, Zhang Z, Wan X, Huang B, et al. COVID-19: immunopathogenesis and Immunotherapeutics. Signal Transduction and Targeted Therapy. 2020;5(1). [DOI:10.1038/s41392-020-00243-2]
2. World Health Organization. Available from: https://covid19.who.int/. . 2021.
3. Sefidkar R, Madadizadeh F. A summary of the main actions of the Iranian government during the Covid-19: From March 5 until December 20 in 2020. Journal of Community Health Research. 2021;10(1):1-3. [DOI:10.18502/jchr.v10i1.5825]
4. Jazieh AR. COVID-19 Pandemic as a Catalyst for Healthcare Transformation: Finding the Silver Lining in a Global Catastrophe. Innovative Healthcare Institute; 2020. [DOI:10.36401/JQSH-20-X5]
5. Fereydoun Azizi. Lifestyle changes to prevent important non-communicable diseases. Iranian Journal of Endocrinology and Metabolism. 1381 [cited 2021May07]; 4 (2 (Series 14)): 81-84. Available from: https://www.sid.ir/fa/journal/ViewPaper.aspx?id=28223. 1381.
6. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases. 2021.
7. !!! INVALID CITATION !!! (6).
8. Sun J, Wang B, Niu Y, Tan Y, Fan C, Zhang N, et al. Complexity analysis of EEG, MEG, and fMRI in mild cognitive impairment and Alzheimer's disease: a review. Entropy. 2020;22(2):239. [DOI:10.3390/e22020239]
9. Basu S. Non-communicable Disease Management in Vulnerable Patients During Covid-19. Indian journal of medical ethics. 2020(2):103-5. [DOI:10.20529/IJME.2020.041]
10. Bahariniya S, Asar ME, Madadizadeh F. COVID-19: Pros and cons of different caring techniques of elderly patients. Journal of Education and Health Promotion. 2021;10.
11. Chang A, Cullen M, Harrington R, Barry M. The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review. Journal of Internal Medicine. 2020. [DOI:10.1111/joim.13184]
12. Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its Impact on Patients with COVID-19. SN Comprehensive Clinical Medicine. 2020:1-8. [DOI:10.1007/s42399-020-00363-4]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License.

© 2024 CC BY 4.0 | Journal of Community Health Research

Designed & Developed by : Yektaweb